The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.
| Product Specifications | |
| Application | FC |
| Reactivity | Human |
| Conjugation | PE |
| Peptide Sequence | TLADFDPRV |
| Class | Class I |
| Sequence Location | 883-891 |
| MHC Allele | A*02:01 |
| Documents & Links for HLA-A*02:01 EphA2 Tetramer-TLADFDPRV-PE | |
| Datasheet | HLA-A*02:01 EphA2 Tetramer-TLADFDPRV-PE Datasheet |
| Documents & Links for HLA-A*02:01 EphA2 Tetramer-TLADFDPRV-PE | |
| Datasheet | HLA-A*02:01 EphA2 Tetramer-TLADFDPRV-PE Datasheet |
